Associated Papers
Whole exome sequencing of high-risk neuroblastoma identifies novel non-synonymous variants.
Przybyła W et al.
Plos One, 2022
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer.
Sivapiragasam A et al.
Cancer Medicine, 2021
33314633 (PubMed )
Supplement: CAM4-10-53-s003.xlsx › Sheet1
Stage IV Colorectal Cancer Patients with High Risk Mutation Profiles Survived 16 Months Longer with Individualized Therapies.
Hendricks A et al.
Cancers, 2020
32046290 (PubMed )
Supplement: cancers-12-00393-s001.zip › cancers-698395-2.revision.supplementary_materials › SuppTables_S1-S7_.xlsx › S6_German_patients_mutations
Truncation- and motif-based pan-cancer analysis reveals tumor-suppressing kinases.
Hudson AM et al.
Science Signaling, 2018
Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling.
Cornen S et al.
Plos One, 2014
24416132 (PubMed )
Supplement: pone.0081843.s021.xlsx › Table_S5B
Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer.
Barber LJ et al.
Plos One, 2011
Select a paper to view details